CRESCENT BIOPHARMA INC

CBIONASDAQ

🏆 #2376 by market capEarnings Nov 5US Equity

$16.69▼ $0.62 (−3.69%)

Market closed · at close

1h—

24h▼ 3.7%

7d—

14d—

30d—

1y—

🏦Market Cap

$595M

Small Cap

📈Revenue Growth (YoY)

—

📊Gross Margin

—

💵FCF Margin

—

⚖️P/S Ratio

52.6x

Expensive

Otter Score

53

Weak

Earnings

Q3 · 2026Reported 2026-07-30

Earnings Per Share

Actual

-0.74

Expected

-0.74

miss

−0.60%

YoY +85.00%

Revenue

Actual

—

Expected

$357.14K

—

—

Consensus estimates

Recent quarters

Q3 2026

-0.74

miss

Q2 2026

-0.70

beat

Q1 2026

-4.01

miss

Q4 2025

-1.27

miss